Arbutus Biopharma Corp Strategic Asset Allocation Index
Arbutus Biopharma Corp strategic asset allocation index. Arbutus Biopharma Corp (ABUS) has a Strategic Asset Allocation Index of 0.0% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $97.37 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Arbutus Biopharma Corp tangible equity quality to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Arbutus Biopharma Corp (2000–2024)
Strategic asset allocation index of Arbutus Biopharma Corp from 2000 to 2024. This chart shows how Arbutus Biopharma Corp's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2024. As of December 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $97.37 Million USD.
Arbutus Biopharma Corp Strategic Asset Allocation Index by Year (2000–2024)
Arbutus Biopharma Corp strategic asset allocation index by year from 2000 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Arbutus Biopharma Corp from 2000 to 2024, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ABUS market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $97.37 Million | ▼ -5.9 pp |
| 2023 | 5.9% | $6.28 Million | $- | $6.28 Million | $106.02 Million | ▼ -25.1 pp |
| 2022 | 31.0% | $42.43 Million | $5.07 Million | $37.36 Million | $136.85 Million | ▲ +6.4 pp |
| 2021 | 24.6% | $41.67 Million | $5.98 Million | $35.69 Million | $169.44 Million | ▲ +17.8 pp |
| 2020 | 6.8% | $6.93 Million | $6.93 Million | $0.00 | $101.97 Million | ▼ -5.1 pp |
| 2019 | 11.9% | $8.68 Million | $8.68 Million | $0.00 | $72.74 Million | ▼ -4.2 pp |
| 2018 | 16.2% | $32.37 Million | $10.14 Million | $22.22 Million | $200.23 Million | ▲ +9.5 pp |
| 2017 | 6.7% | $12.18 Million | $12.18 Million | $0.00 | $182.50 Million | ▲ +3.3 pp |
| 2016 | 3.4% | $6.95 Million | $6.95 Million | $0.00 | $203.00 Million | ▲ +1.0 pp |
| 2015 | 2.4% | $13.25 Million | $3.18 Million | $10.07 Million | $547.68 Million | ▲ +0.4 pp |
| 2014 | 2.0% | $1.76 Million | $1.76 Million | $- | $88.00 Million | ▼ -0.3 pp |
| 2013 | 2.3% | $1.37 Million | $1.37 Million | $- | $59.19 Million | ▼ -1.0 pp |
| 2012 | 3.3% | $1.36 Million | $1.36 Million | $0.00 | $40.92 Million | ▼ -38.1 pp |
| 2011 | 41.4% | $2.15 Million | $2.15 Million | $0.00 | $5.21 Million | ▲ +12.3 pp |
| 2010 | 29.1% | $3.12 Million | $3.12 Million | $0.00 | $10.73 Million | ▲ +21.6 pp |
| 2009 | 7.5% | $2.67 Million | $2.67 Million | $0.00 | $35.44 Million | ▲ +1.9 pp |
| 2008 | 5.6% | $2.14 Million | $2.14 Million | $0.00 | $38.29 Million | ▼ -2.7 pp |
| 2007 | 8.3% | $1.53 Million | $1.53 Million | $0.00 | $18.37 Million | ▼ -313.2 pp |
| 2006 | 321.5% | $500.04K | $500.04K | $0.00 | $155.53K | ▲ +312.1 pp |
| 2003 | 9.4% | $4.10 Million | $4.10 Million | $0.00 | $43.38 Million | ▲ +1.2 pp |
| 2002 | 8.3% | $3.75 Million | $3.75 Million | $0.00 | $45.35 Million | ▲ +3.7 pp |
| 2001 | 4.5% | $2.79 Million | $2.79 Million | $0.00 | $61.49 Million | ▼ -3.6 pp |
| 2000 | 8.1% | $2.44 Million | $2.44 Million | $0.00 | $30.03 Million | — |